Spots Global Cancer Trial Database for diagnostic test
Every month we try and update this database with for diagnostic test cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Virtual Biopsy Development to Identify Patient's Glioma Grade at the CHU of Poitiers Using Magnetic Resonance Imaging | NCT04313140 | Development of ... Tumor Grade Artificial Inte... Clinical Radiological | Diagnostic test | 18 Years - | Poitiers University Hospital | |
| Combined Breast Cancer Risk Study | NCT03067389 | Hereditary Canc... | Diagnostic test | 18 Years - 84 Years | Myriad Genetic Laboratories, Inc. | |
| Virtual Biopsy Development to Identify Patient's Glioma Grade at the CHU of Poitiers Using Magnetic Resonance Imaging | NCT04313140 | Development of ... Tumor Grade Artificial Inte... Clinical Radiological | Diagnostic test | 18 Years - | Poitiers University Hospital | |
| Contents of Circulating Extracellular Vesicles: Biomarkers in Colorectal Cancer Patients | NCT04523389 | Colorectal Canc... | analysis (prote... Gathering addit... Diagnostic test | 18 Years - | Centre Hospitalier Universitaire Dijon | |
| Using Liquid Biopsy in Newly Diagnosed Patients With High Grade Adenocarcinoma of Ovarian Origin, Fallopian Tubes or Primary Peritoneal | NCT04511988 | Ovarian Cancer | Diagnostic Test | 18 Years - | Institut de Cancérologie de Lorraine | |
| Diagnostic Accuracy Study for OWL-EVO1 as a Lung Cancer EVOC® Probe (Evolution Phase 2) | NCT06193239 | Lung Cancer | OWL-EVO1 | 45 Years - 85 Years | Owlstone Ltd | |
| Assessing Tissue Remodeling in the Skin Using SFI (Skin Fluorescence Imaging) | NCT03535077 | Skin Lesion Melanoma (Skin) Mole | Diagnostic Test | 21 Years - | Orlucent, Inc | |
| Combined Breast Cancer Risk Study | NCT03067389 | Hereditary Canc... | Diagnostic test | 18 Years - 84 Years | Myriad Genetic Laboratories, Inc. | |
| Urinary Excretion of Acetylamantadine by Cancer Patients | NCT00755898 | Cancer | Ingestion of a ... Ingestion of a ... | 18 Years - 85 Years | University of Manitoba | |
| WATS3D for the Detection of Esophageal Dysplasia | NCT03008980 | Barrett Esophag... Esophageal Dysp... Esophagus Adeno... | Diagnostic Test | 18 Years - | CDx Diagnostics | |
| Contents of Circulating Extracellular Vesicles: Biomarkers in Colorectal Cancer Patients | NCT04523389 | Colorectal Canc... | analysis (prote... Gathering addit... Diagnostic test | 18 Years - | Centre Hospitalier Universitaire Dijon | |
| Wide Area Transepithelial Sample Esophageal Biopsy Combined With Computer Assisted 3-Dimensional Tissue Analysis (WATS3D) For the Detection of High Grade Esophageal Dysplasia and Adenocarcinoma | NCT03015389 | Barrett Esophag... Esophageal Dysp... Esophageal Aden... | Diagnostic Test | 18 Years - | CDx Diagnostics | |
| WATS3D for the Detection of Esophageal Dysplasia | NCT03008980 | Barrett Esophag... Esophageal Dysp... Esophagus Adeno... | Diagnostic Test | 18 Years - | CDx Diagnostics | |
| Virtual Biopsy Development to Identify Patient's Glioma Grade at the CHU of Poitiers Using Magnetic Resonance Imaging | NCT04313140 | Development of ... Tumor Grade Artificial Inte... Clinical Radiological | Diagnostic test | 18 Years - | Poitiers University Hospital | |
| Diagnostic Accuracy Study for OWL-EVO1 as a Lung Cancer EVOC® Probe (Evolution Phase 2) | NCT06193239 | Lung Cancer | OWL-EVO1 | 45 Years - 85 Years | Owlstone Ltd | |
| Contrast-enhanced Spectral Mammography (CESM) Early Quantitative Evaluation of Tumoral Response and Pathologic Complete Response Prediction for Localized Breast Cancer Treated by Neoadjuvant Chemotherapy | NCT06299202 | Breast Cancer | Diagnostic test | 35 Years - | Hospices Civils de Lyon | |
| Diagnostic Accuracy Study for OWL-EVO1 as a Lung Cancer EVOC® Probe (Evolution Phase 2) | NCT06193239 | Lung Cancer | OWL-EVO1 | 45 Years - 85 Years | Owlstone Ltd | |
| Investigation of the Contents and Prognostic Values of Glucose Metabolism Molecules in Patients With Lung Adenocarcinoma | NCT03641105 | Lung Cancer Glycolysis Diagnosis Survival | Diagnostic test | 18 Years - | Shanghai Zhongshan Hospital | |
| Urinary Excretion of Acetylamantadine by Cancer Patients | NCT00755898 | Cancer | Ingestion of a ... Ingestion of a ... | 18 Years - 85 Years | University of Manitoba | |
| Safety and Dose Ranging Study for OWL-EVO1 as a Lung Cancer EVOC® Probe (Evolution) | NCT05510674 | Lung Cancer | OWL-EVO1 | 18 Years - 80 Years | Owlstone Ltd | |
| Wide Area Transepithelial Sample Esophageal Biopsy Combined With Computer Assisted 3-Dimensional Tissue Analysis (WATS3D) For the Detection of High Grade Esophageal Dysplasia and Adenocarcinoma | NCT03015389 | Barrett Esophag... Esophageal Dysp... Esophageal Aden... | Diagnostic Test | 18 Years - | CDx Diagnostics | |
| Safety and Dose Ranging Study for OWL-EVO1 as a Lung Cancer EVOC® Probe (Evolution) | NCT05510674 | Lung Cancer | OWL-EVO1 | 18 Years - 80 Years | Owlstone Ltd | |
| Mutational Oncology in Clinical Practice | NCT06020625 | Genome Instabil... Genetic Predisp... Gene Rearrangem... | Diagnostic Test | 18 Years - | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | |
| Mutational Oncology in Clinical Practice | NCT06020625 | Genome Instabil... Genetic Predisp... Gene Rearrangem... | Diagnostic Test | 18 Years - | Fondazione Policlinico Universitario Agostino Gemelli IRCCS |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
